In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 4.1K citations · Full text

Antibiotic Adjuvant, Mrsa Strains, Dermatology +18

Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase

Elizabeth A. Campbell, Nataliya Korzheva, Arkady Mustaev et al. · Cell · 2001 · 1.5K citations · Full text

Antibacterial Agent, Microbiology, Molecular Microbiology +5

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

Helen W. Boucher, Mark Wilcox, George H. Talbot et al. · New England Journal of Medicine · 2014 · 420 citations · Full text

Organism Profile in Periprosthetic Joint Infection: Pathogens Differ at Two Arthroplasty Infection Referral Centers in Europe and in the United States

Vinay K. Aggarwal, Hooman Bakhshi, Niklas Unter Ecker et al. · The Journal of Knee Surgery · 2014 · 244 citations · Full text

Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue

Michael W. Dunne, Sailaja Puttagunta, Craig R. Sprenger et al. · Antimicrobial Agents and Chemotherapy · 2015 · 224 citations · Full text

Extended-duration Dosing, Staphylococcus Aureus, Pharmacotherapy +19